Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie J Lipka

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cardiovascular Drug Reviews|December 4, 2003
Ezetimibe: a first-in-class, novel cholesterol absorption inhibitorLeslie J Lipka
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 24, 2007
Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylateDean J Kereiakes, Joel M Neutel, Henry A Punzi, et al.
The American Journal of Cardiology|February 15, 2003
Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemiaBoris Kerzner, John Corbelli, Stephan Sharp, et al.
Journal of the American College of Cardiology|December 31, 2002
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaMichael H Davidson, Thomas McGarry, Robert Bettis, et al.
The American Journal of Cardiology|November 9, 2002
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemiaCarlos A Dujovne, Mark P Ettinger, J Frederick McNeer, et al.
Circulation|April 30, 2003
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialChristie M Ballantyne, John Houri, Alberto Notarbartolo, et al.
The Lancet. Neurology|December 23, 2008
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyWerner Hacke, Anthony J Furlan, Yasir Al-Rawi, et al.
The New England Journal of Medicine|March 27, 2012
Vorapaxar in the secondary prevention of atherothrombotic eventsDavid A Morrow, Eugene Braunwald, Marc P Bonaca, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cardiovascular Drug Reviews|December 4, 2003
Ezetimibe: a first-in-class, novel cholesterol absorption inhibitorLeslie J Lipka
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 24, 2007
Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylateDean J Kereiakes, Joel M Neutel, Henry A Punzi, et al.
The American Journal of Cardiology|February 15, 2003
Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemiaBoris Kerzner, John Corbelli, Stephan Sharp, et al.
Journal of the American College of Cardiology|December 31, 2002
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaMichael H Davidson, Thomas McGarry, Robert Bettis, et al.
The American Journal of Cardiology|November 9, 2002
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemiaCarlos A Dujovne, Mark P Ettinger, J Frederick McNeer, et al.
Circulation|April 30, 2003
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialChristie M Ballantyne, John Houri, Alberto Notarbartolo, et al.
The Lancet. Neurology|December 23, 2008
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled studyWerner Hacke, Anthony J Furlan, Yasir Al-Rawi, et al.
The New England Journal of Medicine|March 27, 2012
Vorapaxar in the secondary prevention of atherothrombotic eventsDavid A Morrow, Eugene Braunwald, Marc P Bonaca, et al.
Pageof 1